Analyst Ratings for Iovanace Biotherapeutics (IOVA)
IOVA Rating Summary
IOVA Price Target Summary
- Highest: $14.00 (Wells Fargo)
- Lowest: $1.00 (Goldman Sachs)
- Average: $7.50
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$7.50 (+91.8%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
Avg. $ Target:
$7.50 (+91.8%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/25/2026 | Citizens » Updated 6/1/2026 |
Reni J. Benjamin | Upgrade | Market Outperform (Market Perform) |
5.00 (N/A) |
2.89 (3.91) |
35.29% | Details |
| 7/15/2025 | Goldman Sachs | Andrea Newkirk | Downgrade | Sell (Buy) |
1.00 (8.00) |
1.87 (3.91) |
109.09% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
